These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7905027

  • 1. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease.
    Ichai C, Chevallier N, Delaere P, Dournaud P, Epelbaum J, Hauw JJ, Vincent JP, Checler F.
    J Neurochem; 1994 Feb; 62(2):645-55. PubMed ID: 7905027
    [Abstract] [Full Text] [Related]

  • 2. Alterations of peptide metabolism and neuropeptidase activity in senile dementia of the Alzheimer's type.
    Waters SM, Davis TP.
    Ann N Y Acad Sci; 1997 Apr 24; 814():30-9. PubMed ID: 9160957
    [Abstract] [Full Text] [Related]

  • 3. Metabolic half-life of somatostatin and peptidase activities are altered in Alzheimer's disease.
    Weber SJ, Louis RB, Trombley L, Bissette G, Davies P, Davis TP.
    J Gerontol; 1992 Jan 24; 47(1):B18-25. PubMed ID: 1346149
    [Abstract] [Full Text] [Related]

  • 4. Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes.
    Mentlein R, Dahms P.
    J Neurochem; 1994 Jan 24; 62(1):27-36. PubMed ID: 7903352
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P, Katzman R, Terry RD.
    Nature; 1980 Nov 20; 288(5788):279-80. PubMed ID: 6107862
    [Abstract] [Full Text] [Related]

  • 9. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D, Rossor MN, Mountjoy CQ, Roth M, Emson PC.
    Neurosci Lett; 1986 Sep 25; 70(1):154-9. PubMed ID: 2877420
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neuropeptide-hydrolysing activities in synaptosomal fractions from dog ileum myenteric, deep muscular and submucous plexi. Their participation in neurotensin inactivation.
    Barelli H, Ahmad S, Kostka P, Fox JA, Daniel EE, Vincent JP, Checler F.
    Peptides; 1989 Sep 25; 10(5):1055-61. PubMed ID: 2575247
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Brain gamma-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease.
    Sherif F, Gottfries CG, Alafuzoff I, Oreland L.
    J Neural Transm Park Dis Dement Sect; 1992 Sep 25; 4(3):227-40. PubMed ID: 1627256
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alterations of substance P metabolism and neuropeptidases in Alzheimer's disease.
    Waters SM, David TP.
    J Gerontol A Biol Sci Med Sci; 1995 Sep 25; 50(5):B315-9. PubMed ID: 7545530
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.